手机网
关键词
首页>>正文

NESTOR:伴有微蛋白尿的高血压2型糖尿病患者的治疗[Treatment of hypertensive type 2 diabetes patients with microalbuminuria]
[2006/12/15 0:00:00]
 全文(共1页)

Presse Med. 2002 Oct;31 Spec No 2:S21-3. Links Service d"Endocrinologie et de Diabetologie, Hopital Bichat, Paris (75).

PRIMARY OBJECTIVE: The first fundamental study devoted to the reduction of microalbuminuria with a antihypertensive diuretic (indapamide SR) in type 2 diabetes with hypertension, the Marre study (NESTOR) was designed to demonstrate that this antihypertension agent could be an interesting therapeutic alternative by comparing its efficacy on microalbuminuria with that of enalapril 10 mg during a treatment period of 52 weeks.

RESULTS: It was demonstrated that indapamide SR is the only diuretic providing a significant reduction (35%) in the microalbuminuria observed in hypertensive patients with type 2 diabetes. At the endpoint, comparison with the group of patients treated with enalapril, showed no significant difference in fractionated albumin clearance or in the percentage of patients with normoalbuminuria, microalbuminuria or gross proteinuria. Safety and tolerance were comparable for the two treatments.




 
更多热点
更多   心血管   相关搜索
声明:登陆《国际循环》手机网不收业务信息费,只产生运营商收取的上网流量费。
返回顶端| About Us | 客服中心 |收藏本站
WapURL手机网址(wap.icirculation.com)